Competition Likely to Heat Up in RA Biologics Market Although Growth Continues

With the debut of new drugs and increasing efforts to obtain expanded indications, there are growing signs that competition among biologics for the treatment of rheumatoid arthritis (RA) will further intensify. The entry of a biosimilar is expected as well...read more